170 related articles for article (PubMed ID: 25548844)
1. A prospective rater- and subject-blinded study comparing the efficacy of incobotulinumtoxinA and onabotulinumtoxinA to treat crow's feet: a clinical crossover evaluation.
Muti G; Harrington L
Dermatol Surg; 2015 Jan; 41 Suppl 1():S39-46. PubMed ID: 25548844
[TBL] [Abstract][Full Text] [Related]
2. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet.
Saybel A; Artemenko A; Nikitin S; Kurenkov A
J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
Ascher B; Rzany BJ; Grover R
Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
[TBL] [Abstract][Full Text] [Related]
4. Different injection patterns of incobotulinumtoxinA for crow's feet: a split-face comparative study.
Vachiramon V; Subpayasarn U; Triyangkulsri K; Jurairattanaporn N; Rattananukrom T
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):256-262. PubMed ID: 33068445
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
Muti GF; Basso M
J Clin Aesthet Dermatol; 2017 Sep; 10(9):27-29. PubMed ID: 29344324
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial.
Moers-Carpi M; Carruthers J; Fagien S; Lupo M; Delmar H; Jones D; Somogyi C; Lee E; Lei X; MacKinnon S; Davis PG; Yalamanchili R; Campo A; Beddingfield FC
Dermatol Surg; 2015 Jan; 41(1):102-12. PubMed ID: 25485803
[TBL] [Abstract][Full Text] [Related]
7. A randomized, patient/evaluator-blinded, split-face study to compare the efficacy and safety of polycaprolactone and polynucleotide fillers in the correction of crow's feet: The latest biostimulatory dermal filler for crow's feet.
Jeong GJ; Ahn GR; Park SJ; Hong JY; Kim BJ
J Cosmet Dermatol; 2020 Jul; 19(7):1593-1599. PubMed ID: 31680395
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study.
Elridy AS; Zaki RGE; Elshinawy RF
Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961
[TBL] [Abstract][Full Text] [Related]
9. Lifting effect of onabotulinumtoxinA in patients treated for glabellar and crow's feet rhytids.
Norman S
J Cosmet Laser Ther; 2020 Nov; 22(6-8):232-238. PubMed ID: 33944656
[TBL] [Abstract][Full Text] [Related]
10. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
Prager W; Rappl T
J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
[TBL] [Abstract][Full Text] [Related]
12. A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles.
Yeilding RH; Fezza JP
Plast Reconstr Surg; 2015 May; 135(5):1328-1335. PubMed ID: 25919246
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet.
Lowe NJ; Ascher B; Heckmann M; Kumar C; Fraczek S; Eadie N;
Dermatol Surg; 2005 Mar; 31(3):257-62. PubMed ID: 15841623
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous crow's feet line patterns and customized botulinum toxin rejuvenating treatment.
Cavallini M; Papagni M; Augelli F; Muti GF; Santorelli A; Raichi M
J Cosmet Dermatol; 2022 Oct; 21(10):4294-4300. PubMed ID: 35723939
[TBL] [Abstract][Full Text] [Related]
15. Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus Lines.
Soares DJ; Dejoseph LM; Zuliani GF; Liebertz DJ; Patel VS
Dermatol Surg; 2015 Jun; 41(6):712-7. PubMed ID: 25973563
[TBL] [Abstract][Full Text] [Related]
16. Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.
Kassir R; Kolluru A; Kassir M
Dermatol Ther (Heidelb); 2013 Dec; 3(2):179-89. PubMed ID: 24318416
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial.
Carruthers A; Bruce S; de Coninck A; Connolly S; Cox SE; Davis PG; Campo A; Lei X; Somogyi C; Lee E; McLean H; Beddingfield F
Dermatol Surg; 2014 Nov; 40(11):1181-90. PubMed ID: 25347451
[TBL] [Abstract][Full Text] [Related]
18. Introduction of the Microdroplet Technique with Incobotulinumtoxin A for the Treatment of Crow's Feet.
Imhof M; Kuhne U
J Clin Aesthet Dermatol; 2013 Jul; 6(7):40-4. PubMed ID: 23882314
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study.
Levy JL; Servant JJ; Jouve E
J Cosmet Laser Ther; 2004 May; 6(1):16-20. PubMed ID: 15370408
[TBL] [Abstract][Full Text] [Related]
20. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
Lowe NJ; Lask G; Yamauchi P; Moore D
J Am Acad Dermatol; 2002 Dec; 47(6):834-40. PubMed ID: 12451366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
